Cargando…
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma
SIMPLE SUMMARY: The survival of advanced melanoma patients has been improved in recent years due to immunotherapy. However, not all patients respond to this treatment. For this reason, it is necessary to know the mechanisms of the response and resistance to immunotherapy. In this work, clinical samp...
Autores principales: | Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Prado-Vázquez, Guillermo, López-Vacas, Rocío, Soriano, Virtudes, Garicano, Fernando, Lecumberri, M. José, Rodríguez de la Borbolla, María, Majem, Margarita, Pérez-Ruiz, Elisabeth, González-Cao, María, Oramas, Juana, Magdaleno, Alejandra, Fra, Joaquín, Martín-Carnicero, Alfonso, Corral, Mónica, Puértolas, Teresa, Ramos-Ruiz, Ricardo, Dittmann, Antje, Nanni, Paolo, Fresno Vara, Juan Ángel, Espinosa, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486782/ https://www.ncbi.nlm.nih.gov/pubmed/37686682 http://dx.doi.org/10.3390/cancers15174407 |
Ejemplares similares
-
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2023) -
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics
por: Gámez-Pozo, Angelo, et al.
Publicado: (2017) -
A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities
por: López-Camacho, Elena, et al.
Publicado: (2023) -
Bayesian networks established functional differences between breast cancer subtypes
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020) -
Proteomics Characterization of Clear Cell Renal Cell Carcinoma
por: Miranda-Poma, Jesús, et al.
Publicado: (2023)